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Abstract
Quantitative nuclear magnetic resonance imaging (MRI) has been considered a promising
non-invasive tool for monitoring therapeutic essays in small size mouse models of muscular
dystrophies. Here, we combined MRI (anatomical images and transverse relaxation time
constant—T2—measurements) to texture analyses in the study of four mouse strains cov-
ering a wide range of dystrophic phenotypes. Two still unexplored mouse models of muscu-
lar dystrophies were analyzed: The severely affected Largemydmouse and the recently
generated and worst double mutantmdx/Largemydmouse, as compared to the mildly affect-
edmdx and normal mice. The results were compared to histopathological findings. MRI
showed increased intermuscular fat and higher muscle T2 in the three dystrophic mouse
models when compared to the wild-type mice (T2:mdx/Largemyd: 37.6±2.8 ms;mdx: 35.2
±4.5 ms; Largemyd: 36.6±4.0 ms; wild-type: 29.1±1.8 ms, p<0.05), in addition to higher mus-
cle T2 in themdx/Largemydmice when compared tomdx (p<0.05). The areas with in-
creased muscle T2 in the MRI correlated spatially with the identified histopathological
alterations such as necrosis, inflammation, degeneration and regeneration foci. Neverthe-
less, muscle T2 values were not correlated with the severity of the phenotype in the 3 dys-
trophic mouse strains, since the severely affected Largemyd showed similar values than
both the mildmdx and worstmdx/Largemyd lineages. On the other hand, all studied mouse
PLOSONE | DOI:10.1371/journal.pone.0117835 February 24, 2015 1 / 16
a11111
OPEN ACCESS
Citation: Martins-Bach AB, Malheiros J, Matot B,
Martins PCM, Almeida CF, Caldeira W, et al. (2015)
Quantitative T2 Combined with Texture Analysis of
Nuclear Magnetic Resonance Images Identify
Different Degrees of Muscle Involvement in Three
Mouse Models of Muscle Dystrophy: mdx, Largemyd
and mdx/Largemyd. PLoS ONE 10(2): e0117835.
doi:10.1371/journal.pone.0117835
Academic Editor: Vincent Mouly, Institut de
Myologie, FRANCE
Received: August 19, 2014
Accepted: January 1, 2015
Published: February 24, 2015
Copyright: © 2015 Martins-Bach et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by Fundação de
Amparo a Pesquisa do Estado de São Paulo - Centro
de Pesquisa, Inovação e Difusão - FAPESP-CEPID,
grant numbers 1998/14254-2 and 2013/08028-1
(http://cepid.fapesp.br), Conselho Nacional de
Desenvolvimento Científico e Tecnológico - CNPq-
INCT, grant number 573633/2008-8 (http://inct.cnpq.
br/), Coordenação de Aperfeiçoamento de Pessoal
strains could be unambiguously identified with texture analysis, which reflected the ob-
served differences in the distribution of signals in muscle MRI. Thus, combined T2 intensity
maps and texture analysis is a powerful approach for the characterization and differentiation
of dystrophic muscles with diverse genotypes and phenotypes. These new findings provide
important noninvasive tools in the evaluation of the efficacy of new therapies, and most im-
portantly, can be directly applied in human translational research.
Introduction
The muscular dystrophies are an extensive group of genetic diseases where the major charac-
teristic is the progressive muscle degeneration, caused by mutations in genes coding for sarco-
lemmal, sarcomeric, cytosolic, nuclear or extracellular matrix proteins. The absence or altered
function of one of these proteins is responsible for a cascade of events which ends in the muscle
fibers degeneration and substitution by connective and adipose tissue. The patients present
progressive weakness, starting at different ages depending on the mutation. Up to now, there is
no effective cure for this group of diseases, and several therapeutic protocols are in develop-
ment [1, 2].
The most frequent form of muscular dystrophy is Duchenne Muscular Dystrophy (DMD),
caused by mutations in the dystrophin gene and with an incidence of 1 in 3300 live male births
[3, 4]. The dystrophin protein is part of the dystrophin-glycoprotein complex (DCG), which
links the cytoskeleton from muscle fibers to the extracellular matrix. This connection is mediat-
ed by the dystroglycan complex, composed by the sarcolemmal beta-dystroglycan (β-DG) sub-
unit and the peripheral membrane alpha-dystroglycan (α-DG). While β-DG links to the
subsarcolemmal protein dystrophin, α-DG is responsible for the connection with the extracel-
lular matrix protein α-2 laminin. This link occurs via the sugar chains in the glycosylated ex-
tension of α-DG, which have high affinity to Laminin G (LG)-like domains present in various
extracellular matrix proteins, such as laminins, perlecan and agrin in muscle, and neurexin in
brain [5, 6, 7]. Mutations in the gene coding for dystroglycans are very rare, but alterations in
α-DG glycosylation are related to several forms of myopathy, such as limb girdle muscular dys-
trophies and congenital muscular dystrophies [8].
The study of animal models for neuromuscular disorders has an essential role in under-
standing the pathogenetic mechanisms of the muscular diseases and in the development of
therapeutic strategies. There are several natural or created animal models for the different
forms of muscle dystrophy, which can model the genetic, molecular and/or clinical aspects of
the disease. The Dmdmdx mouse (hereafter called simplymdx) is the most frequently used
mouse model for DMD. This mouse has a stop codon in exon 23 of the murine dystrophin
gene, which leads to the total absence of this protein in the muscle, as observed in DMD pa-
tients [3, 9, 10]. Nevertheless, differently from the human patients, themdxmouse can contin-
uously regenerate its muscles and has a mild phenotype, which makes the analysis of
functional benefices in therapeutic protocols very difficult [11, 12].
Double mutant mice with themdx background have been created in the attempt to ap-
proach the severe phenotype observed in DMD patients, such as the double knockoutmdx:
utrn-/-, with absence of both dystrophin and utrophin [13, 14]; themdx/mTRmouse, with im-
paired telomerase activity [15]; and the Dmdmdx-Largemyd mouse (hereafter calledmdx/Large-
myd), recently generated in our laboratory by crossingmdx and Largemyd murine lineages [16].
The Largemyd myodystrophy mouse has a mutation in the glycosyltransferase Large gene,
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which leads to reduced glycosylation of α-DG and a severe and progressive myodystrophy.
Mutations in the human gene LARGE are related to congenital muscular dystrophy 1D
(CMD1D), with severe muscle and central nervous system involvement. The double mutant
mdx/Largemyd mouse presents deficiency of both dystrophin and Large proteins, and a very se-
vere phenotype, worse than both parental lineages. The lifespan is reduced and the degree of
muscle degeneration and infiltration by connective tissue is increased when compared to the
parental lineages. Themdx/Largemydmouse gives clues of the interplay between α-DG glycosyl-
ation and dystrophin deficiency and is useful for testing therapies due to the functional, genetic
and protein alterations [16].
Different therapeutic strategies for muscular dystrophies are in development, including ge-
netic and cellular approaches. The gold standard to evaluate the dystrophic muscle is still the
histological analysis, but non-invasive methods are highly desirable. Nuclear magnetic reso-
nance (NMR), and more specifically magnetic resonance imaging (MRI), have a great potential
in the study of skeletal muscle due to its flexibility in generating images from soft tissues with
different contrasts, additionally enabling metabolic and functional studies. MRI studies in dys-
trophic patients have revealed different patterns of muscle involvement depending on the mu-
tation, which can be used to orient the molecular testing in the differential diagnosis [17, 18].
Human DMD clinical evolution and muscle metabolism alterations can be non-invasively
tracked by NMR, with a good correlation between quantitative NMR parameters and the clini-
cal evaluation [19, 20, 21, 22, 23, 24, 25, 26].
When applied to small animals, MRI faces the challenge of reducing dimensions and in-
creasing resolution. Additionally, differently from human patients, mouse models of
muscular dystrophies present low to zero fat infiltration in the muscle [27, 28]. The MRI anal-
ysis of intra-muscular fat infiltration is therefore not as informative in mice as it is in patients,
which prompted the search for other MRI approaches to non-invasively evaluate mouse mod-
els, such as transverse relaxation time constant (T2) measurements and muscle
texture analysis.
T2 is an NMR value intrinsic for each type of tissue, reflecting the motility of its water pro-
tons. When the examined tissue presents pathologic processes such as necrosis, inflammation
or edema, this dynamic is altered, which results in changes in the tissue T2. Previous studies
have reported abnormal muscle T2 in some dystrophic models, such asmdx [28, 29, 30], γ-sar-
coglycan knock-out γsg-/- [29], α-sarcoglycan knock-out sgca-/- [31], and α-2 laminin deficient
dy/dy and dy2J/dy2J mouse models [32], as compared to normal controls. Texture analysis is an
emerging approach that includes several techniques to quantify variations in the image intensi-
ty or patterns. When applied to muscle MRI, texture analysis has demonstrated to be a poten-
tial tool to evaluate subtle differences in the pattern of distribution of muscle lesions [33, 34,
35]. In themdxmouse [36] and the GRMD dystrophic dog [37], longitudinal studies were able
to correlate texture parameters with age and progression of the disease.
Considering this, we hypothesized that T2 measurements combined to muscle MRI texture
analysis would be sensitive enough to characterize and differentiate dystrophic muscle pheno-
types caused by different gene mutations. Here, we used this approach to evaluate two still un-
explored mouse models of muscular dystrophies, the recently generatedmdx/Largemyd mouse
and the Largemyd parental lineage, in addition tomdx and C57Bl mice. These mouse strains
cover a wide range of dystrophic phenotypes, with variable degrees of muscle necrosis and in-
flammation, and could be unambiguously identified with quantitative muscle T2 and texture
analysis. The new findings will have important applications to noninvasive follow of potential
therapeutic protocols.
Quantitative NMR of Mouse Models to Muscle Dystrophy
PLOS ONE | DOI:10.1371/journal.pone.0117835 February 24, 2015 3 / 16
Material and Methods
Ethics Statement
All the experiments were approved by the Research Ethics Committee of the Biosciences Insti-
tute, University of São Paulo, protocol 176/2013.
Animals
Four mouse strains were evaluated: the dystrophicmdx, Largemyd andmdx/Largemyd, in addi-
tion to C57Bl/6 mice as normal controls (wild-type). 47 mice, aged between 2 and 4 months
(8–19 weeks), both male and female, were studied: 9 double mutantsmdx/Largemyd, 13mdx, 12
Largemyd and 13 wild-type. As the two models with a weaker phenotype, in particularmdx/Lar-
gemyd mice, are difficult to obtain (25% of affected sibling and high degree of perinatal death,
[16]), a more flexible range of ages was adopted. To homogenize the groups, the accepted age
range was allowed to vary between 8 and 18 weeks for all mouse strains. At this stage, muscle
dystrophy is patent in all mouse strains. This age range is posterior to the critical period inmdx
mice, when a peak of myofiber necrosis, muscle weakness and regeneration is observed be-
tween the 2nd and the 5th weeks of life [38]. All the animals were from the Human Genome Re-
search Center animal house, Bioscience Institute (Sao Paulo). The mice were kept in controlled
environment, with water and food at libidum.
Magnetic Resonance Imaging acquisition and analysis
The mice were anesthetized with intraperitoneal injection of ketamine:xylazine (2:1, 1.5–2.5 μl/
g according to the lineage) and symmetrically positioned for the MRI acquisitions. The images
were acquired in a 2 tesla/30 cm bore superconducting magnet (Oxford Instruments 85310HR,
Abingdon, United Kingdom), interfaced to a Bruker Avance AVIII console (Bruker-Biospin,
Inc., Billerica, MA, U.S.A.) running PARAVISION 5.0. A crossed-saddle radiofrequency coil
projected for small animals [39] was used to image the mice's posterior limbs.
Four scans were performed in each mouse, with the same geometry (4 slices, 1.5 mm slice
thickness, 4 mm inter-slice distance and spatial resolution 0.176X0.176 mm2/pixel): two scans
for anatomical images with the same parameters (repetition time-TR = 1800 ms, echo time -
TE = 52.5 ms), with and without fat suppression for qualitative evaluation of possible fat infil-
tration in the muscles (with fat suppression:16 averages; without fat suppression: 4 averages);
and two scans for the calculation of the T2 maps, each one using a different echo time (to avoid
the contribution of stimulated echoes): TE1 = 12.1 ms and TE2 = 40 ms (TR = 1500 ms, 1 aver-
age when TE1 = 12.1 ms, 4 averages when TE2 = 40 ms, spatial resolution: 0.176X0.176 mm
2/
pixel). The T2 value for each pixel was calculated using the Bloch equation for the spin-spin re-
laxation time (S1 Supporting Information), and T2 maps were generated using a routine devel-
oped in the MATLAB software (The MathWorks, Inc., Natick, Massachusetts, USA). The total
acquisition time was 51 minutes. The examination time never exceeded 1 hour and 30 minutes.
In the T2 maps, two slices were selected for analysis: one positioned at the lower leg and one
at the thigh. One slice was considered representative of thigh and leg muscles since injured fi-
bers would present anomalies along all its length. Nevertheless, this limits the analysis to the
muscles observed in a defined anatomical position.
Four Regions of Interest (ROI) were evaluated: two in the lower leg T2 map, at the posterior
and anterior compartment muscles, and two in the thigh T2 maps, covering the medial and lat-
eral muscles. The ROIs were drawn to exclude any non-muscle tissue. For each ROI, the mean
T2 value and the standard deviation were analyzed.
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The muscle texture in MRI was evaluated with the softwares MaZda 4.6 and B11 3.3 [40, 41,
42], using the T2-weighted images acquired with TE = 40 ms and TR = 1500 ms. The lower leg
image was selected and one ROI was drawn in the left lower leg of each mouse, including all
muscle groups but excluding subcutaneous fat, bones and skin. All the 371 texture features of-
fered by the Mazda software were calculated. The co-occurrence matrices parameters contrast
and entropy were selected due to their significance for the identification of our studied groups,
and resulted in the reduction of the 371 features to 40. Among them, Mazda software automati-
cally selected 30 features, by combining the maximization of the Fischer coefficients, the maxi-
mization of the mutual information between two selected features, the minimization of the
classification error probability and minimization of the average correlation coefficients (F+PA
+MI). The 30 selected features (listed in S2 Supporting Information) were then used as input to
Linear Discriminant Analysis (LDA) in the software B11.
Histological analysis
Two days after the NMR session the mice were euthanized in a CO2 chamber. The whole left
leg was collected and preserved in formaldehyde solution (4% in Phosphate Buffer Saline -
PBS). The right leg was dissected and the lower leg posterior compartment (gastrocnemius and
soleus) was imbedded in Tissue-tek OCT freezing medium (Optimal Cutting Temperature,
Sakura Finetek USA, Torrance, CA, USA) and frozen in liquid nitrogen.
The histological qualitative evaluation was performed on at least 2 mice for each lineage.
The formaldehyde preserved samples were decalcified and embedded in plastic resin according
to the manufacturer procedure (HistoResin, Leica, Wetzlar, Germany). Resin embedded sam-
ples were cut in 5 μm slices and frozen samples were cut in 8 μm slices. Both frozen and resin
embedded histological sections were stained with Hematoxilin and Eosin (H&E). Additional
Gomori trichrome and sirius red staining were done in the frozen sections.
Statistic analysis
The T2 mean values for each ROI were analyzed with a three-factors ANOVA, followed by
the Bonferroni muticomparison test when ANOVA detected differences (p<0.05). The three
considered factors were: presence of the mutation in the dystrophin gene (Dmd+/+ = no muta-
tion/Dmd-/- = with mutation); presence of the mutation in the gene Large (Large+/+ = no mu-
tation/Large-/- = with mutation); and muscle group (1: lower leg posterior, 2: lower leg
anterior, 3: thigh lateral, 4: thigh medial). The lineage was split in two factors to evaluate a
possible cumulative effect of both mutations in the double mutantmdx/Largemyd mouse, and
the muscle groups were studied separately to evaluate a possible different pattern of muscle in-
volvement in the dystrophic mouse strains. The differences were considered significant when
p<0.05. This level of significance was achieved in ANOVA when F(1,164)>3.90 for the com-
parison of mice from different genetic background and when F(3,164)>2.66 for the compari-
son of different muscle groups. Analyses were performed with NCSS 2001 software (Kaysville,
Utah, USA).
Results
The three dystrophic mouse strains showed increased amount of fat between the muscles when
compared to the wild-type mice (Fig. 1). However, no intra-muscular fat could be detected in
any of the mouse strains with MRI: the muscle hyperintensities present in the images without
fat suppression (Fig. 1, NFS) were identically observed in the images with fat suppression
(Fig. 1, FS), indicating that these areas were not related to fat infiltration.
Quantitative NMR of Mouse Models to Muscle Dystrophy
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Muscle T2
In the individual comparison between muscle groups for each lineage, only the wild-type mice
showed differences: thigh medial muscles have higher muscle T2 than the lower leg muscles
(p<0.01). In the three dystrophic strains no differences were observed between the muscle
groups. Therefore, all muscles were grouped in one unique T2 value for each animal for the
comparison between the mouse strains (Table 1).
No differences were observed between the muscle groups in the three dystrophic mouse
strains. p-values are for the comparisons between muscle groups for each mouse strain. Since
four individual comparisons were done, the Bonferroni correction was applied and the differ-
ences were considered significant if p<0.0125.
Considering the mouse strains individually, muscle T2 was markedly increased in the three
dystrophic mouse models when compared to the wild-type mice (p<0.05). Additionally,mdx/
Largemyd mice had significantly higher muscle T2 thanmdxmice (p<0.05, Table 1, Fig. 2).
Fig 1. Intermuscular fat in dystrophicmice.MRI of the four mouse strains (lower leg), showing intermuscular fat but no visible fat infiltration in the muscles
in the three dystrophic strains. The arrows indicate the presence of fat between the muscles, as bright areas in the non fat-supressed images (NFS) and dark
areas in the images with fat suppression (FS). The arrowheads indicate hyperintense areas present in the images with and without FS, which are therefore
not related to fat infiltration. TE = 52.5 ms, TR = 1800 ms.
doi:10.1371/journal.pone.0117835.g001
Table 1. T2 per muscle group in milliseconds for the four mouse strains studied.
mdx/Largemyd mdx Largemyd wild-type
N 9 13 12 13
Lower leg - posterior 36.96 ± 2.84 34.95 ± 3.70 35.48 ± 2.15 28.34 ± 1.71
Lower leg - anterior 37.15 ± 3.77 33.43 ± 2.85 33.95 ± 3.59 28.05 ± 1.28
Thigh - lateral 37.70 ± 3.07 36.41 ± 7.20 37.79 ± 5.38 29.69 ± 1.36
Thigh - medial 38.34 ± 1.66 36.31 ± 3.00 38.48 ± 2.54 30.36 ± 1.93
Comparison between muscles p = 0.76 p = 0.32 p = 0.025 p<0.01
All muscles 37.56 ± 2.82 35.23 ± 4.53 36.58 ± 4.00 29.11 ± 1.82
doi:10.1371/journal.pone.0117835.t001
Quantitative NMR of Mouse Models to Muscle Dystrophy
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When considering the effect of each gene mutation separately in muscle T2 values, ANOVA
showed that there was a significant interaction between the absence of dystrophin and the de-
fective glycosylation of α-DG (p<0.001). The presence of both mutations lead to an increase in
muscle T2 when compared to themdxmice, but this increase was lower than the simple sum of
the effects of each mutation (Fig. 3).
Muscle texture analysis
Despite similar values of T2, it was possible to observe differences in the distribution of hyper-
intense regions in muscle MRI: whilemdxmice presented focal areas with hyperintense signal
randomly distributed in the muscles (patchy), Largemyd mice presented a global increase in
muscle signal, distributed homogeneously in all muscles (waxy). The double mutantmdx/Lar-
gemyd presented a waxy aspect in muscle images, with a few focal hyperintense areas, as a mix-
ture of the patterns observed in the parental strains. The differences in global appearance
observed visually in the muscle images from the dystrophic mice were then quantified using
texture analysis algorithms. The four groups were properly distinguished with the constructed
model, and all the individuals were correctly classified by it. The linear separability was 0.91
and 3 dimensions could model 97% of the original data. Plotting the data over the three dimen-
sions of the model nicely visualized the clustering of the mice into four groups according to the
mutation (Fig. 4).
Histological analysis
The histological analysis was based on qualitative comparison of dystrophic pathologic fea-
tures, such as the presence of degenerating and regenerating cells foci, necrosis, and infiltration
Fig 2. Muscle T2 formdx/Largemyd, Largemyd, mdx and wild-typemice.Muscle T2 in milliseconds for the four mouse strains evaluated. *: Muscle T2
different from wild-type mice; #: muscle T2 different frommdxmice.
doi:10.1371/journal.pone.0117835.g002
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by connective and adipose tissues. Homogeneous and pale eosinophilic sarcoplasm was related
to degenerating and necrotic fiber, while basophilic sarcoplasm and central nuclei were related
to regenerating fibers (Fig. 5) [43, 44].
Histological sections from the resin embedded samples, which preserved the anatomical or-
ganization of the muscle groups, where chosen to represent the MRI slices (Fig. 6).
Themdxmice showed a patchy pattern in the MRI (Fig. 6C), and the hyper-signal areas in
MRI corresponded spatially to foci of dystrophic alterations, such as clusters of degenerating
and regenerating cells, infiltration by inflammatory cells and spots of adipose tissue in the pe-
riphery of the muscles (Fig. 6G, K). It was also possible to observe variation in the fibers caliber,
Fig 3. Effect of eachmutation onmuscle T2. Both the dystrophin absence and the α-DG glycosylation defect increase muscle T2, but the combination of
both does not produce an additive effect.
doi:10.1371/journal.pone.0117835.g003
Fig 4. Texture analysis differentiates the four mouse strains. Two views of the same plot showing the clustering of mice groups after texture analysis
from lower leg MRI. 1: wild-type, 2:mdx/Largemyd, 3: Largemyd, 4:mdxmice. MDF: Most Discriminant Features.
doi:10.1371/journal.pone.0117835.g004
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high proportion of centronucleated muscle fibers and increased amount of connective tissue in
all the lower leg muscles, but these alterations did not necessarily correlate with hyperintense
areas in the MRI.
The Largemyd mice presented dystrophic histological characteristics distributed in a more
diffuse pattern through the muscles, in accordance with the waxy pattern observed in the MRI
(Fig. 6B, F). The histological analysis revealed the presence of degenerating and regenerating
muscle cells, inflammatory infiltrates and fibrosis in a diffuse distribution, with occasional
small clusters of degenerating and regenerating fibers. The muscles were generally more com-
promised than in themdxmice (Fig. 6J).
Themdx/Largemyd mice showed infiltration by inflammatory cells, fibrosis and degenerating
fibers diffusely distributed across the muscles, such as the Largemyd mice, especially in the pos-
terior compartment muscles of the leg. Additionally, there were few big clusters of degenerating
and regenerating fibers which co-localize with hyper-signal areas in the MRI, but in a less ac-
centuated proportion than in themdxmice (Fig. 6A, E). In general, themdx/Largemyd mice
presented a more severe degree of dystrophic lesions in the histological analysis than both pa-
rental mouse strains (Fig. 6I).
The wild-type mice showed polygonal fibers with regular size and peripheral nuclei. There
was no fat accumulation inside the muscles, and between the muscles the amount of fat was re-
duced in comparison to the three dystrophic mouse strains. The endomysial and perimysial
connective tissue were thinner than in the three dystrophic mouse strain (Fig. 6H, L). The nor-
mal histological pattern was compatible with the homogeneous and low intensity signal in
muscle MRI (Fig. 6D).
Discussion
Noninvasive tools for muscle evaluation have an immediate application in therapeutic proto-
cols, to follow possible benefits in longitudinal studies with minimal impact on the subjects.
For this purpose, it is essential that the selected tool could not only detect differences between
dystrophic and normal muscle, but that it could also detect more subtle differences between
various degrees of muscle involvement, both in patients and in animal models. In this MRI
study, we have evaluated for the first time the muscle MRI pattern in the Largemyd and the dou-
ble mutantmdx/Largemyd mouse models of muscular dystrophy, as compared tomdx and
C57Bl/wild-type mice. These mouse strains cover a wide range of dystrophic phenotypes, from
the mildly affectedmdxmouse to the severely compromisedmdx/Largemyd mouse. Using a
combined approach including qualitative MRI evaluation, muscle T2 relaxometry and texture
Fig 5. Identification of dystrophic pathological structures. Histological sections of a 3 month-oldmdx/Largemydmouse (frozen sample), approximately at
the same position, stained with (A) Hematoxilin-Eosin, (B) Sirius Red, and (C) Gomori trichrome, magnification X 100. The arrows indicate thick areas of
connective tissue.
doi:10.1371/journal.pone.0117835.g005
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analysis, in comparison to the standard histological analysis, we have shown that noninvasive
MRI can successfully discriminate muscles from these four mouse strains.
MRI acquired with and without fat saturation revealed no identifiable fat infiltration in the
muscles of any of the mouse strains, but an increased fat accumulation between the muscles in
the MRI could be observed in the dystrophic mice when compared to the wild-type. This obser-
vation was confirmed by the histological analysis, where it was possible to identify bigger fat
deposits between the muscles in the dystrophic mouse strains. Our results extend to the more
severely dystrophic Largemyd andmdx/Largemyd models the previously described MRI findings
in themdxmouse, of no fat infiltration in skeletal muscles visible with MRI [28, 29, 36].
In addition to the increased intermuscular fat, the histological analysis revealed sporadic ad-
ipose cells in the muscles of the three dystrophic mouse strains, notably in themdxmice,
where small clusters of adipose cells were present especially along the fascia. This is in accor-
dance with previous MRI observation in DMD patients, where increased fat signal along the
fascia in young DMD boys was present even when the intramuscular fat replacement was mini-
mal [45]. Although no fat infiltration could be observed in the mice MRI, we believe that the
presence of only sporadic and isolated adipose cells in the muscle would not be visually
Fig 6. MRI versus histological analysis.MRI (A-D; TE = 40 ms, TR = 1500 ms) and histological images (H&E, magnification X12: E-H; magnification X200:
I-L) of the left lower leg frommdx/Largemyd (A, E, I), Largemyd (B, F, J),mdx (C, G, K) and wild-type mice (D, H, L). The regions highlighted in the MRI (first
row) and in the whole lower leg histological image (second row) are presented in a higher magnification in the third row. Different histological processes could
be related to the hyperintensities regions in the MRI, such as clusters of degenerating cells (I), regenerating and adipose cells cells (K), and regions with
mixed dystrophic characteristics (J).
doi:10.1371/journal.pone.0117835.g006
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detected in the MRI in the resolution used in this study. It is possible though that this punctual
presence of fat in the muscle can lead to changes in the muscle T1 and T2 measurements, in ad-
dition to alterations in the MRI muscle texture.
The quantitative evaluation of the mean muscles T2 showed increased values for the three
dystrophic mouse strains when compared to the wild-type mice. An increased but not cumula-
tive effect of the dystrophin absence and the α-DG glycosylation defect was observed in the
double mutantmdx/Largemyd mouse: its muscle T2 was higher than the value observed in the
mdxmouse, but it was not different from the Largemyd mouse. The increased muscle T2 in the
dystrophic mice is in accordance with previous studies showing higher muscle T2 in themdx
mouse [28, 29, 30], and in other mouse models of muscular dystrophies such as laminin-defi-
cient mice [32] and the γ-sarcoglycan-null mice [29]. Our NMR study in Largemyd andmdx/
Largemyd mice extend the number of dystrophic mouse models where increased muscle T2 is
observed, corroborating the hypothesis that even if no significant fat infiltration is observed in
the MRI of murine models of muscle dystrophy, increased muscle T2 would be a common fea-
ture of the dystrophic muscle, both in patients and animal models with variable phenotype.
Muscle water T2 reflects the mobility of water molecules in the tissue. The loss of muscle
proteins, the presence of infiltrated adipose and inflammatory cells, and the edema originated
by inflammation and necrosis in the dystrophic muscle lead to alterations in the mobility of
water molecules, and consequently can contribute to the T2 alterations [46]. The absence of
the dystrophin protein destabilizes the DGC and leads to increased membrane damage in the
mdxmouse. Sarcolemma disruption and increased cell permeability cause edema and extrava-
sation of the sarcoplasmatic content [47], with consequent altered mobility of water molecules
and increased T2. Even if themdxmouse has a mild phenotype, the membrane disruptions are
present in higher proportion when compared to the more severely affected α-2 laminin-
deficient mice, dy/dy and dy2J/dy2J [46]. The same pathological disruption of the sarcolemma is
observed in cardiac muscle cells from Largemyd mice [48], and is possibly present also in the
skeletal muscles from Largemyd and the double mutantmdx/Largemyd mice. Thus, sarcolemma
disruption, in addition to the consequent necrosis and inflammatory infiltrates observed in
areas with hyperintense signal in the MRI, could be more related to the increased muscle T2 in
the three dystrophic mouse strains, than the overall phenotype.
The T2 determination based on two echoes at two different TEs has long been dismissed as
inadequate and imprecise. This needs to be revised and our data bring more evidence pointing
into that direction. When image signal-to-noise ratio is high, two-point determination is accu-
rate, often more than CPMG echo trains. In practice, scanner imperfections but also RF propa-
gation through tissues create B1 field deviations that are responsible for the generation of
stimulated echoes that bias the T2 decay. Most often, the measured mono-exponential T2 with
this sequence is longer than the true T2. The single echo collection as was performed here pre-
vents the introduction of stimulated echos. While obsolete at first glance, the method used here
is in reality as valid as and probably more accurate than more popular methods.
We are here dealing with mono-exponential T2, that is classically used to characterize global
water T2 dynamics in a given tissue. Muscle T2 decay is in reality multi-exponential and can be
exploited to determine tissue water compartments and exchanges, as shown by the work by
Saab [49] and more recently by Araujo [50]. It requires different and very demanding experi-
mental approaches, which are seldom used in practice. In that respect, standard multi-echo se-
quences do not allow better than the 2 echoes method to tackle this multi-compartment
organization of tissue.
In the comparison between MRI and the histological analysis, appropriate co-localization of
the distribution of alterations was observed in the three dystrophic mouse strains, which is es-
sential to validate the use of MRI as an outcome measure. In humans, a correlation between
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the degree of muscle involvement in MRI and the progression of dystrophic alterations in his-
tological analysis was observed in DMD patients, but with MRI and muscle biopsy done in dif-
ferent muscles [51]. In themdxmouse, our data comparing the histological analysis with the
MRI in the same muscles showed that high intensity areas in muscle MRI were co-localized
with variable dystrophic characteristics in the histological analysis, in accordance with the pre-
vious studies in this model [28]. Additionally, we extended for the first time this characteriza-
tion for Largemyd andmdx/Largemyd dystrophic murine models, which showed a similar co-
localization of alterations in the MRI versus the histological analysis. In all these dystrophic
models the areas with increased muscle T2 in the MRI correlated spatially with several different
histopathological alterations such as necrosis, inflammation, degeneration or regeneration foci.
Thus, even if the increased muscle T2 could not differentiate individually each one of these
pathological findings, the T2 maps reveal a disease process at a tissue level. Apart of the non-in-
vasive nature, this MRI approach allows the evaluation of the dystrophic process along several
muscles in the same exam, which is methodologically difficult considering the use of standard
histological techniques.
Muscle T2 values were not correlated with the severity of the phenotype in the 3 dystrophic
mouse strains, since the severely affected Largemyd mice showed similar values than both the
mildmdx and severemdx/Largemyd lineages. Notably, the major histological difference between
these strains is fibrosis, which was not detectable with the MRI sequences used in this study.
Connective tissue presents very short T2 values, being visualized only with appropriated pulse
sequences such as Ultra Short Echo-time sequences (UTE) [52], which could not be used due
to technical limitations. On the other hand, the MRI images showed clear different patterns of
muscle signals. The muscle MRI was patchy inmdxmice, with delimited regions of increased
MR signal distributed through the posterior limb muscles, both in the lower leg and in the calf
images. The Largemydmice, by its turn, showed a waxy pattern in the muscle MRI, with a gener-
al increase in the MR signal distributed homogeneously through the lower leg and thigh mus-
cles. Finally, themdx/Largemyd mice showed generally a diffuse increase in the MR signal, like
the Largemyd mice, but there were also hyperintense regions in the lower leg muscles, similar to
what was observed in themdxmice. After refining the muscle texture analysis with the evalua-
tion of the co-occurrence matrix parameters entropy and contrast, it was possible to cluster the
mice from different groups.
Changes in the muscle texture in small animals have already been reported in rats when
comparing atrophic, regenerating and normal muscles [34]. In themdxmodel, a heterogeneous
muscle signal was also observed in a variable degree according mouse’s age, with a peak be-
tween the age of 5 and 17 weeks [36]. Additionally, texture parameters have been considered
reliable biomarkers of disease progression in the GRMD dystrophic dog [53, 37]. Here we
show the possibility of classifying murine models of muscle dystrophies with different pheno-
types using quantitative NMR and texture analysis with prior knowledge. It is possible that the
differences observed with our texture analysis were more evident due to the mice’s age, since it
was close to the described peak of muscle heterogeneity in themdxmodel [36]. Even though,
these results indicate that MRI when combined to texture analysis can provide a refined nonin-
vasive identification of muscle alterations, not only between drastically different conditions but
also when more subtle differences are present. This approach can be potentially transferred to
human applications. In this case, a preliminary step would be to select the most discriminant
combination of texture indices in muscle MRI from patients with known diagnosis. Then, the
model could be validated by investigating in which category new patients would be classified in
confront with genetic analysis.
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Conclusion
While muscle mean T2 values were abnormal in all dystrophic muscle, and reflected the spatial
distribution of different histopathological changes, they did not clearly distinguish the three
different genotypes, nor were correlated to severity of the phenotype. On the other hand, tex-
ture analysis algorithms unambiguously separated muscles frommdx, Largemyd andmdx/Lar-
gemyd mice, reflecting the waxy versus patchy distribution of lesions in the different strains.
Combined T2 maps and texture analysis provide a powerful non-invasive characterization of
dystrophic muscles, even when performed at 2 teslas and derived from two single TEs measure-
ments. Our findings have important implications to validate the use of MRI as an outcome
measure in therapeutic protocols applied to mouse models of muscle dystrophies, with the pos-
sibility of direct applications in human translational research.
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